Genetic causes of neonatal encephalopathy and related conditions
Official title: Genetics of Neonatal Encephalopathy and Related Disorders
Run by Boston Children's Hospital · NCT07165938 · Data updated 2026-11-12
This project will see if DNA changes help explain neonatal encephalopathy in children under 6 who receive care at Boston Children's Hospital.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | February 4, 2026 |
| Main results expected | September 2035 |
| Study ends | September 2035 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07165938 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children diagnosed with neonatal encephalopathy during the neonatal period who are under 6 years old at enrollment and are patients at Boston Children's Hospital, with biological parents eligible to provide samples.
✕Probably not a fit
Patients who already have a known genetic cause for their neonatal encephalopathy, who died before enrollment, or who are not patients at Boston Children's Hospital are not likely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational effort enrolls children diagnosed with neonatal encephalopathy during the newborn period (and, when available, their biological parents) who are patients at Boston Children's Hospital. Investigators collect clinical information from the medical record and biological samples for genetic testing to look for DNA variants that may cause or contribute to the condition. Genetic findings are then compared with each child's clinical features and outcomes to identify patterns and potential genetic causes. The work is noninterventional and focuses on improving diagnostic understanding rather than testing a treatment.
Why it matters
Potential benefit: If successful, this work could lead to more accurate diagnoses, better genetic counseling for families, and improved management plans for affected children.
How similar studies have gone: Previous genetic sequencing efforts have identified pathogenic variants in some infants with neonatal encephalopathy, but applying genetics broadly to NE is still emerging and not yet definitive for all cases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Proband Criteria: Inclusion Criteria: * Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record * Less than 6 years old at the time of study enrollment * Patient at Boston Children's Hospital Exclusion Criteria: * Genetic cause of NE already identified * Deceased prior to enrollment Parent criteria: Inclusion Criteria: \- Biological parent of eligible proband (see above)
Where it's running
-
Boston Children's Hospital
Boston, Massachusetts, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using breast milk to treat brain injury in newborns
This study is testing if giving breast milk through the nose can help newborns with brain injuries feel better and develop normally while they are being treated with cooling therapy.
-
Newborn Brain Wave Checker: See if CergenX Wave matches the Sarnat exam
This study tests whether the CergenX Wave software, which analyzes a newborn's EEG via a small four-electrode setup, can match the standard Sarnat examination in babies with suspected neonatal encephalopathy.
-
Neonatal Neurological Observation With Video AI
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
-
Using intranasal breast milk to improve outcomes in newborns with brain injury
This study is testing if giving fresh breast milk through the nose can help newborns with brain injury do better in the long run compared to standard care.
-
Virtual intervention for at-risk children with neurological issues
This study is testing if a virtual program can help young children with neurological issues, like those born prematurely, just as well as in-person help does.
-
Using sildenafil to treat brain injury in newborns after asphyxia
This study is testing if sildenafil can help newborns with brain injuries from lack of oxygen at birth recover better after treatment with cooling therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.